22-46219983-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005036.6(PPARA):​c.680T>C​(p.Val227Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00364 in 1,614,026 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 18 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 127 hom. )

Consequence

PPARA
NM_005036.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.771

Publications

69 publications found
Variant links:
Genes affected
PPARA (HGNC:9232): (peroxisome proliferator activated receptor alpha) Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027141273).
BP6
Variant 22-46219983-T-C is Benign according to our data. Variant chr22-46219983-T-C is described in ClinVar as Benign. ClinVar VariationId is 770476.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00501 (763/152198) while in subpopulation EAS AF = 0.0432 (224/5186). AF 95% confidence interval is 0.0386. There are 18 homozygotes in GnomAd4. There are 443 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 763 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PPARANM_005036.6 linkc.680T>C p.Val227Ala missense_variant Exon 7 of 9 ENST00000407236.6 NP_005027.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PPARAENST00000407236.6 linkc.680T>C p.Val227Ala missense_variant Exon 7 of 9 1 NM_005036.6 ENSP00000385523.1
PPARAENST00000402126.2 linkc.680T>C p.Val227Ala missense_variant Exon 6 of 8 1 ENSP00000385246.1
PPARAENST00000493286.1 linkn.890T>C non_coding_transcript_exon_variant Exon 6 of 6 1

Frequencies

GnomAD3 genomes
AF:
0.00500
AC:
760
AN:
152080
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0275
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.0431
Gnomad SAS
AF:
0.00312
Gnomad FIN
AF:
0.00302
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.0112
AC:
2820
AN:
251378
AF XY:
0.00915
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.0486
Gnomad ASJ exome
AF:
0.00466
Gnomad EAS exome
AF:
0.0441
Gnomad FIN exome
AF:
0.00366
Gnomad NFE exome
AF:
0.000413
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00349
AC:
5104
AN:
1461828
Hom.:
127
Cov.:
31
AF XY:
0.00327
AC XY:
2381
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.0481
AC:
2152
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00325
AC:
85
AN:
26136
East Asian (EAS)
AF:
0.0503
AC:
1995
AN:
39696
South Asian (SAS)
AF:
0.00268
AC:
231
AN:
86258
European-Finnish (FIN)
AF:
0.00403
AC:
215
AN:
53366
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.000136
AC:
151
AN:
1112010
Other (OTH)
AF:
0.00416
AC:
251
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
311
622
933
1244
1555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00501
AC:
763
AN:
152198
Hom.:
18
Cov.:
32
AF XY:
0.00595
AC XY:
443
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41540
American (AMR)
AF:
0.0277
AC:
423
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.0432
AC:
224
AN:
5186
South Asian (SAS)
AF:
0.00312
AC:
15
AN:
4810
European-Finnish (FIN)
AF:
0.00302
AC:
32
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68000
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00332
Hom.:
35
Bravo
AF:
0.00811
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00958
AC:
1163
Asia WGS
AF:
0.0170
AC:
58
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PPARA-related disorder Benign:1
Jan 27, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.31
DEOGEN2
Benign
0.11
T;T;T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.55
D
LIST_S2
Benign
0.82
T;.;.
MetaRNN
Benign
0.0027
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
0.77
PrimateAI
Benign
0.34
T
PROVEAN
Benign
1.1
N;N;N
REVEL
Benign
0.080
Sift
Benign
1.0
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.056
ClinPred
0.0047
T
GERP RS
4.2
Varity_R
0.12
gMVP
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800234; hg19: chr22-46615880; COSMIC: COSV53078755; COSMIC: COSV53078755; API